Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3b Open-label Study of Lusutrombopag in Thrombocytopenic Patients With Chronic Liver Disease
jRCT2080222971Phase 3
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of lusutrombopag in Thrombocytopenia and chronic liver disease (CLD), sponsored by Shionogi & Co., Ltd.
02
Drugs
lusutrombopag
03
Conditions
Thrombocytopeniachronic liver disease (CLD)
Beyond the preview
Go deeper on jRCT2080222971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222971.